-
Open Access Bioinformatics
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Microarray oligonucleotide probe designer: a Web service
Methodology
(1616) Views (298) Full article downloads
Authors: Viren C Patel, Kajari Mondal, Amol Carl Shetty, et al
Published Date November 2010
Volume 2010:2 Pages 145 - 155
DOI: http://dx.doi.org/10.2147/OAB.S13741
Viren C Patel1*, Kajari Mondal1*, Amol Carl Shetty1*, Vanessa L Horner1, Jirair K Bedoyan2, Donna Martin2,3, Tamara Caspary1, David J Cutler1, Michael E Zwick1
1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA; 2Department of Pediatrics, 3Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA; *These authors contributed equally to this work.
Abstract: Methods of genomic selection that combine high-density oligonucleotide microarrays with next-generation DNA sequencing allow investigators to characterize genomic variation in selected portions of complex eukaryotic genomes. However, choosing the specific oligonucleotides to be used can pose a major technical challenge. To address this issue, we have developed a software package called MOPeD (microarray oligonucleotide probe designer), which automates the process of designing genomic selection microarrays. This Web-based software allows individual investigators to design custom genomic selection microarrays optimized for synthesis with Roche NimbleGen’s maskless photolithography. Design parameters include uniqueness of the probe sequences, melting temperature, hairpin formation, and the presence of single-nucleotide polymorphisms. We generated probe databases for the human, mouse, and rhesus macaque genomes and conducted experimental validation of MOPeDdesigned microarrays in human samples by sequencing the human X chromosome exome, where relevant sequence metrics indicated superior performance relative to a microarray designed by the Roche NimbleGen proprietary algorithm. We also performed validation in the mouse to identify known mutations contained within a 487-kb region from mouse chromosome 16, the mouse chromosome 16 exome (1.7 Mb), and the mouse chromosome 12 exome (3.3 Mb). Our results suggest that the open source MOPeD software package and Web site (http://moped.genetics.emory.edu/) will make a valuable resource for investigators in their sequence-based studies of complex eukaryotic genomes.
Keywords: genomic selection, oligonucleotide, microarray, next-generation sequencing, software
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Pharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms
Erratum - Intracellular heavy metal nanoparticle storage
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- Discrimination between biological interfaces and crystal-packing contacts
- A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells




